We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


In Vitro DDI Drug Transporter Studies | ADME 101 Webinar: Efflux and Uptake Transporters

Presented by Andrew Taylor, Ph.D., Services Technical Support Manager

Drug transport can be thought of as the AD&E in ADME, as transporters are responsible for absorption, distribution, tissue-specific drug targeting, and elimination of drugs. Since they are involved in so much of the movement of a compound through the body, they can be involved in many drug‒drug interactions (DDI). The clearance of transporter substrates can be impacted by transporter inhibitors or inducers which can lead to toxicity or loss of efficacy.

Key concepts discussed in this mini-webinar:

  • An overview of drug transporters, including ATP-binding cassette (ABC) and solute carrier (SLC)
  • Why drug transporter studies are important, including a real-world example
  • An explanation of transporter expression and function
  • Regulatory guidance on transporters, including FDA, EMA & PMDA
  • Inhibition and substrate transporter study design, including Efflux Transporter Transwell Assays, SLC Transporter Uptake Assays, and BSEP and MRP2 Vesicle Assays
  • An example of study result data
  • Different transporter study and test system options and more…

Download slides: https://www.xenotech.com/webinar-slides/sekisui-xenotech_drug-transport-adme-101.pdf

Questions, comments and requests: https://www.xenotech.com/contact-us
More information on our research services and test systems: https://www.xenotech.com

Other previously aired webinars: https://www.xenotech.com/scientific-resources/webinar-series

Upcoming webinar notifications: https://www.xenotech.com/newsletter-signup

Request a webinar topic: https://www.xenotech.com/scientific-resources/upcoming-webinars

About the presenter: Dr. Andrew G. Taylor received his Ph.D. from the University of California San Diego. He joined SEKISUI XenoTech as a research scientist in 2017, serving as a Study Director in nonclinical drug interaction contract studies in compliance with Good Laboratory Practices (GLP), OECD Principles of GLP, &/or Japan MOHW GLP Standards and specializing in drug transport and drug metabolism studies. He became the Technical Support Manager for services in 2020 and provides valuable guidance to ensure research needs are being met.